Dr. Jose Gomez-Arroyo chats with us after an exciting session - “True Grit: Tales of Impactful Science in Drug Developement Clinical Trials Global Registries and Biobanks in PAH”
A wonderful talk from Dr. Paul Yu about the inspirational discovery and development process for activin ligand traps for PAH at this morning’s True Grit session @ats@SueGuMD ⭐️⭐️
https://t.co/6ics0sMmeM
Check out our last episode of Practical PH where @mmcirulis and @KCoxFlaherty have an important talk with Drs. Hemnes and Sontag @VApccm @mdlizs about reproductive health in PH 📣📣
One of my favorite parts of #ATS2024 is being reminded how collaborative our field is! Had such a great time getting feedback on our preliminary work of MELD-Na as a predictor of PAH severity which is mediated by pathways of inflammation. @atsearlycareer@ATS_PC
Catch the action on the ground! @mmcirulis chats with Dr. Boucly about her talk this morning on monotherapy or dual therapy in PAH patients with cardiovascular comorbidities 📣
Hot takes from @navneetsinghmd with Dr. Khushboo Goel from “It’s (not) a small world: molecular and physiologic epidemiology in PAH” @BrownPVD@CSPCCM#ATS2024
Wrapping up Legoland with a discussion with @Montanidavid and @mmcirulis about his talk on the highly anticipated results re the impact of genetic background on clinical effect of sotatercept in PAH 🧬
Corey Ventetuolo just gave an incredibly inspiring talk on Navigating Sinkholes on the road to promotion. Learning to negotiate for opportunities that move your career forward is hard but she gave us great points to do so! #ATS2024@atscommunity@ATS_PC@BrownOWIMS@BrownMedPhys
Hot off the press: results from our Randomized, Double-Blind, Placebo-Controlled Trial of Anastrozole in patients with Pulmonary Hypertension (PHANTOM)
https://t.co/FAj0aSHZ5A
@ATSBlueEditor@PHAssociation@ATS_PC@KawutSteven
This work has taken 10 years to get out! The genetics of chronic thromboembolic pulmonary hypertension-a genuine global effort in a rare disease. https://t.co/zXUyT7zBFE
I’m so excited to be sharing our recent publication this morning at the @PVRI Community Call! Please join the discussion- registration is still open: 👇🏽
🚨Manuscript alert! Our group is proud to share our work using novel tissue of PAECs taken from RHC balloons to describe transcriptional profiles of living patients with pulmonary hypertension! We learned so much: a thread 🧵
It’s incredible to finally see our work describing transcriptional profiles of PAECs taken from living PH patients! 😍I’m so thankful to my mentors and collaborators. What an education this has been! https://t.co/errNXKSP9Y @ATS_PC@atsearlycareer@PHAssociation
Why should you come to #ATS2024? Hear from long-time member, supporter and friend of the ATS, Sharon Rounds, MD, as she shares the aspects of the conference that she looks forward to most each year.
🔗Register: https://t.co/CZz4Zk2PTA
In this comprehensive #JACCHF study exploring #HFrEF prescribing, clinical inertia is a main contributor to nonintensification within an updated taxonomy classification for suboptimal #GDMT prescribing. https://t.co/VKHA5615nw
📷 We are highlighting junior investigators! This week is Dr. Shelsey Johnson @shelsey_jane. Shelsey is a PVD fellow @BrighamWomens. Funded by @nih_nhlbi (F32) she focuses on endophenotyping of PH due to lung disease with a goal of identifying treatable subsets! See more below 👇
Join us for an exciting webinar: "Career Development - Negotiating Job Offers 101" Friday, December 1 from 3-4:30 pm EST with leaders in the field, tailored to both clinicians and researchers
Register via the link below 👇
https://t.co/mpGceIgtlY